Within pharmaceutical companies, pharmacovigilance is a core function responsible for the continuous monitoring of medicinal product safety after market authorization. It is a structured and highly regulated system built on defined processes and specialized professionals who operate in accordance with the Good Pharmacovigilance Practices (GVP), the European regulatory framework for pharmacovigilance.
Depending on the company structure, pharmacovigilance may exist as an independent department or be integrated into broader functions such as Medical Affairs or Regulatory Affairs. Regardless of the organizational model, it works closely with departments including Clinical Operations, Regulatory Affairs, and Quality Assurance. As a result, pharmacovigilance contributes to regulatory compliance, process quality, and the proper management of communications with regulatory authorities. Although responsibilities and activities may vary across organizations, the overall objective remains the same: ensuring continuous, accurate, and compliant monitoring of medicinal product safety throughout the product lifecycle.
Key roles in pharmacovigilance
A pharmacovigilance system relies on professionals with operational, scientific, and managerial expertise who contribute to drug safety management in complementary ways. While job titles may differ among companies, several core roles are commonly found within pharmacovigilance organizations.
One of the most common positions is the Drug Safety Specialist or Pharmacovigilance Officer, who is responsible for managing adverse event reports. This professional reviews incoming information, conducts follow-up activities, when necessary, updates safety databases, and ensures adherence to internal procedures.
Supporting this function is the Case Processor, whose primary responsibility is entering data into pharmacovigilance systems and coding information using MedDRA terminology. Although highly standardized, this activity is essential for maintaining the accuracy and quality of safety data.
At a more advanced level, the Safety Scientist or PV Scientist is involved in the clinical assessment of cases, safety signal evaluation, and benefit-risk analysis. This role requires strong medical and scientific expertise as well as advanced analytical skills.
A particularly important position is the QPPV (Qualified Person for Pharmacovigilance), a role required under European legislation. The QPPV serves as the key individual responsible for the company’s pharmacovigilance system and acts as the primary contact point for regulatory authorities such as the EMA and competent national authorities.
From a managerial perspective, the PV Manager or Head of Pharmacovigilance oversees the team, defines operational procedures, and supervises safety-related activities. In addition, this role has a strategic dimension, supporting audits and inspections while ensuring alignment among the various departments involved in pharmacovigilance processes.
Required skills in pharmacovigilance
Working effectively in pharmacovigilance requires a combination of regulatory, scientific, technical, and interpersonal competencies.
Regulatory expertise includes knowledge of Good Pharmacovigilance Practices (GVP), ICH guidelines, and the requirements established by regulatory agencies such as the EMA and national authorities, with particular attention to reporting obligations and timelines. Alongside this, scientific competencies, including pharmacology and clinical medicine, are essential for evaluating adverse events and interpreting the safety profile of medicinal products.
Technical and digital skills are also becoming increasingly important. Daily activities frequently involve the use of pharmacovigilance databases such as Argus, ArisG, or Veeva Safety, as well as MedDRA coding and the management of electronic documentation. Familiarity with quality systems is equally valuable for ensuring compliance with regulatory requirements.
Beyond technical expertise, soft skills play a crucial role. Accuracy and attention to detail are fundamental for maintaining data quality and reliability. Likewise, organizational abilities and the capacity to work within strict deadlines are essential in an environment governed by regulatory timelines.
Strong analytical skills support the interpretation of safety signals and emerging risks. Effective communication is equally important, enabling professionals to interact with internal stakeholders, external partners, and regulatory authorities. Finally, problem-solving capabilities are particularly valuable when dealing with complex cases or situations involving incomplete information.
Conclusion
Overall, pharmacovigilance is a central and cross-functional function within pharmaceutical companies, bringing together scientific, regulatory, and operational expertise.
The various professionals involved contribute in complementary ways toward a common goal: ensuring patient safety through the continuous, structured, and compliant monitoring of medicinal products throughout their entire lifecycle.
References
- European Medicines Agency (EMA) – Good Pharmacovigilance Practices (GVP)
- European Medicines Agency (EMA) – EudraVigilance: Electronic Reporting
- Italian Medicines Agency (AIFA) – Pharmacovigilance Activities and Regulations
- International Council for Harmonisation (ICH) – Medical Dictionary for Regulatory Activities (MedDRA)